Showing 171 - 175 of 175 for "Regulatory" with applied filters
05 June 2019 by
Alexander Robinson and Stephen Garner of Mathys & Squire explore some of the regulatory issues in the life sciences and pharmaceutical sectors that are likely to be affected by Brexit
16 May 2019 by
Paul A Ainsworth and Lauren A Watt of Sterne Kessler Goldstein & Fox examine the extent to which the proposed Biologic Patent Transparency Act will reduce patent thickets, increase transparency and competition in the biologics industry.
24 September 2018 by
Novartis and the NHS’ recent agreement concerning CAR-T therapy is a positive step for adoptive immunotherapy. However, while the future looks bright, the therapy is also subject to threats. Frances Salisbury and Adam Gregory of Mewburn Ellis discuss successes and potential Brexit-related hurdles
01 June 2018 by
The Thai Alcohol Control Act (ACA) B.E. 2551(2008) sets the legal framework for restrictions on alcoholic beverages in Thailand, as well as establishing governmental bodies to oversee such restrictions, i.e. the National Alcohol Beverage Policy Committee and the Alcohol Beverage Control Committee.
01 June 2018 by
A new Code of Conduct for Trans-Tasman Patent and Trade Marks Attorneys (the code) came into effect on February 23 2018 to address two issues